Drooid Logo
Back to today’s briefing

Story perspectives

Patient Sticks to Modern Medicine Amid Rising Cancer Markers

9/23/2025

46 8

1 of 1

Story summary
  • A patient diagnosed with stage 4 ovarian cancer in September 2024 underwent surgery and chemotherapy.
  • She is on maintenance Avastin and Lynparza, but cancer markers are rising.
  • Friends urge ivermectin, but she trusts modern medicine and her doctor.
  • Dr. Roach notes no human studies support ivermectin for cancer and warns against miracle treatments; rely on conventional care.